Skip to content

Impact of Peritoneal Closure and Retroperitoneal Drainage on Patients Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection

Impact of Peritoneal Closure and Retroperitoneal Drainage on Patients Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection for Early Gynecological Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03765320
Enrollment
204
Registered
2018-12-05
Start date
2018-11-06
Completion date
2019-03-25
Last updated
2019-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Cancer, Lymphocele

Brief summary

To elucidate whether peritoneal closure and retroperitoneal drainage can benefit clinical outcome of early gynecologic cancer patients who underwent retroperitoneal lymph node dissection.

Detailed description

To elucidate whether peritoneal closure and retroperitoneal drainage can benefit clinical outcome of early gynecologic cancer patients who underwent retroperitoneal lymph node dissection by reviewing the medical records of patients who underwent retroperitoneal lymph node dissection for stage I or II gynecological cancer in Far Eastern Memorial Hospital, January 2011\ December 2017.

Interventions

PROCEDUREPeritoneal closure

Peritoneal closure after pelvic lymph node dissection for early gynecologic cancer

PROCEDURERetroperitoneal drainage

Retroperitoneal drainage after pelvic lymph node dissection for early gynecologic cancer

Sponsors

Far Eastern Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stage I or stage II gynecologic cancer (including cervical cancer, endometrial cancer, ovarian cancer, and fallopian tube cancer) * Underwent laparotomic gynecologic oncologic surgery, including retroperitoneal lymphadenectomy.

Exclusion criteria

* nil

Design outcomes

Primary

MeasureTime frameDescription
Factors predicting lymphocele occurrence10 yearTo find independent factors that can predict lymphocele occurrence in patients who underwent laparotomic gynecologic oncologic surgery

Secondary

MeasureTime frameDescription
Factors predicting surgical complication10 yearsTo find independent factors that can predict occurrence of surgical complication in patients who underwent laparotomic gynecologic oncologic surgery

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026